CE18 - Innovation biomédicale

Vascularized and perfused skin-on-chip – PerVaSkin

Submission summary

Unveiling skin physiopathology is essential for biological and medicl research. Because animal models fail at predicting human responses to drugs and chemicals in pathology and toxicology, it is crucial to develop skin substitutes with tissue engineering strategies. There are indeed still unmet needs for production of micro-vascularized skin substitutes, which are of utmost importance for investigation of skin diseases, and for evaluation of drug toxicity and availability in skin. The aim of the PerVaSkin project is to develop a vascularized skin-on-chip with perfused capillaries by associating state of the art 3D cell culture and microfabrication. We will use cell sheet-based technology for generating vascularized skin substitutes in their own microenvironment. This engineered tissue will be integrated in microfluidic devices assisted with cell culture automation, thus providing a unique tool for applied skin research, diagnosis and personal medicine using patient-derived skin cells.

Project coordination

Laurent Muller (Centre interdisciplinaire de recherche en biologie)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

CIRB - INSERM U1050 Centre interdisciplinaire de recherche en biologie
IGFL Institut de Génomique Fonctionnelle de Lyon
PASTEUR Processus d'Activation Sélectif par Transfert d'Energie Uni-électronique ou Radiatif

Help of the ANR 432,775 euros
Beginning and duration of the scientific project: December 2021 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter